Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onheal is a South Korean veterinary healthcare and biotechnology company co-founded in 2021 by veterinarians and pharmaceutical distribution experts. The company operates as an animal health bio-hub, facilitating collaborative research, clinical trials, and product distribution between global pharmaceutical firms and local veterinary practices. Onheal's commercial portfolio includes DuraHeart SR-3, a three-month sustained-release heartworm prevention injectable developed in partnership with Inventage Lab, and PlaniCare, a certified medical device for pet skin care. Additionally, the company operates VetUs, an innovative prescription diet shopping platform for animal hospitals, and conducts research into advanced therapeutics, including adult human neural stem cells (AhNSCs) for spinal cord injury and veterinary drugs in collaboration with Rudacure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onheal.